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To determine how a program for learning immunology could be most 
useful for clinicians in South Africa, we consulted with the country’s 
20 leading HIV specialist pediatricians. They told us that immunology 
and its underlying concepts were perceived to be complex and arcane 
and that there was a need for immunology to be better integrated into 
“real-life” clinical practice. Most saw immunology as predominantly 
a laboratory science with little application to clinical practice; this 
highlighted a gap between clinical management of patients and 
theoretical understanding of the etiology and immunopathogenesis 
of disease. We speculated that one of the possible reasons for 
this perception and knowledge gap is that immunology is not an 
independent discipline within the South African medical curriculum. 
Instead, it is diffusely integrated into disciplines such as pathology 
or internal medicine and is not specifically provided for during post-
degree training. 
We initially developed the project Immunopaedia (www.
immunopaedia.org) to help bridge the knowledge gap between 
laboratory research and pediatric HIV clinical science. The rationale 
for Immunopaedia was based on the paradox between the void in 
knowledge of immunology among HIV infectious disease clinicians 
and the need to understand and treat the HIV epidemic in South Africa. 
South Africa has one of the fastest-growing HIV epidemics with over 
5.5 million people living with HIV, many of whom are young children 
and women (1). The 2008 national population-based surveys estimated 
HIV prevalence at 16.9% (2). Provision of treatment and care for such a 
large population makes it hard for HIV clinicians to stay informed about 
the latest developments in infectious disease. Immunopaedia was thus 
created to provide an easy-to-understand summary of the effects of HIV 
infection on the immune system, which could facilitate improvement 
in clinical practice. Immunopaedia has since progressed to include 
more general immunology knowledge that is relevant to other disease 
conditions. We use a clinical case–based perspective to target interns 
in multiple clinical specialities. Immunopaedia is an alternative to more 
advanced online immunology studies that target the basic-science 
student (3). Information and educational materials are available 
through open access, and the site can be used as an adjunct to more 
formal courses or as a stand-alone learning tool. 
Our main method is what we have termed the “Trojan Horse” approach. 
Derived from the Greek Iliad, “Trojan Horse” has come to mean any ploy or 
scheme used to insinuate a rival into a securely protected stronghold. We 
use clinical case studies as our Trojan Horse to tempt clinicians, most of 
whom consider immunology to have little application to clinical needs, to 
engage with immunological concepts relevant to diagnosis and treatment 
(see the figure, above). We explain the key immunological points related 
to the cases by means of a series of graphics. 
The Web site consists of three key components: Clinical Cases, 
Immunology Learning, and Treatment and Diagnostics. At present, 
34 clinical cases are available on the site. In addition to HIV, clinical 
cases span topics such as hypersensitivity, tuberculosis (TB) 
immunopathology, primary and secondary immunodeficiencies, drug 
responses, gastrointestinal disorders, autoimmunity, and malignancies. 
Each of our cases is used to examine an immunological concept that 
leads to greater understanding of the human immune system. For 
example, a case of a 14-year-old boy presenting with severe hip 
pain allowed us to discuss ankylosing spondylitis and to explore the 
concept of mimicry and the “arthritogenic peptide” hypothesis. The 
case of repeated apnea and infections in a premature infant allowed 
us to highlight “physiological immunodeficiency” caused by impaired 
humoral and cellular responses in premature infants, a situation that 
leaves such infants vulnerable to both viral and bacterial pathogens. 
Another presenting case was an 8-month-old boy with recurrent 
infections. We explored the most likely hypothesis, that the mother had 
a primary HIV-1 infection during pregnancy in the third trimester and 
that the child was infected perinatally before maternal seroconversion. 
These are real-life cases, and in the last-mentioned case, as often in real 
life, the underlying immunological problem may not be clear. 
Each case discussion provides, in consecutive windows, patient 
presentation, history, differential diagnosis, examination, investigations, 
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Trojan Horse approach. Immunopaedia uses a case study to lure clinicians 
into learning immunology. Shown are the steps followed for each case before 
posting on the Web site. The case is used to underpin an immunology concept.
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discussion, treatment, and a final outcome. Related case studies are cross-
referenced. Users then evaluate their knowledge and understanding of 
the concepts in the case study by means of questions accompanied by 
explanations. To earn the full quota of continuing medical education 
(CME) points, the user can complete five multiple choice questions for 
each case study that are freely available but require log-in information. 
Integral to our approach with each case study is the use of clear graphics 
to explain the immunological basis and mechanisms underlying the 
condition. The graphics can be downloaded freely as a PDF and used for 
offline reference or for further teaching tools. 
The second key component, Immunology Learning, is divided into 
three main areas: “Immunology” (dealing with the basics), “Childhood 
Diseases and Vaccinations” (dealing with hypersensitivity reactions and 
immune reconstitution, for example), and “Infections” (dealing with a 
range of infections from rickettsia to Guillain-Barré syndrome). 
The third key component, Treatment and Diagnostics, covers information 
related to TB and antiretroviral (ARV) drugs, modes of drug action, the 
HIV life cycle, and specific guidelines for treatment. The “Diagnostic 
Tools” section provides laboratory assay information, such as enzyme-
linked immunosorbent assays (ELISAs), polymerase chain reactions 
(PCRs), and flow cytometry. 
Immunopaedia provides links to other Web sites that focus on medical 
and general aspects of HIV, pediatrics, and treatment guidelines. The 
design of the Web site is such that the user can easily find a source 
of information in the form of a case study, a graphic, or a scientific 
article on specific immunological conditions. In addition, breaking 
scientific news on clinical immunology is posted on the home page and 
is updated daily. Registered users are sent a monthly newsletter that 
coincides with a monthly clinical case study posting. 
For the clinical case component, medical practitioners submit case 
studies from their clinics. Our team of clinical and immunology experts 
reviews and modifies these case studies for presentation on the Web 
site (see the first figure). The rationale behind this approach is that case 
studies from, or closely related to, real situations are effective learning 
tools (4). The case-study approach is a form of experiential learning; it 
integrates practice, knowledge, and skills that further equip clinicians 
in their professional work (5). As the user reads through the case study 
on the site, dividing the case study into stages in separate windows, the 
user is challenged to think about and predict a possible diagnosis based 
on the clinical evidence he or she has just read. This process is similar to 
the way a clinician might operate on the job, and the approach fosters 
lateral and critical thinking, as well as self-guided learning (6). 
Immunopaedia also includes a workshop component as a follow-up 
to the online material (see the second figure). We use the workshops 
to evaluate our new case-study material before posting it on the Web 
site, and our teaching team travels to medical schools within South 
Africa to hold 3-hour sessions for medical interns who are specializing 
in pediatrics, pathology, or internal medicine. The aim of the workshops 
is to create greater awareness and increased use of Immunopaedia as a 
learning site for clinical immunology. 
The monthly average number of unique users was 320 in 2007; 1518 in 
2008; 2326 in 2009; and 1723 in 2010 (through June). Since the site first 
went live, we have received a total of 87,550 visitors, of which 11,520 
have spent more than 5 minutes on the site. Each user who completes 
a case study earns three CME points, and in total, we have awarded 699 
CME points over 3 years. We currently have 892 registered users. 
Future directions for Immunopaedia involve the expansion of our user 
base to include point-of-care clinicians for the ARV drug roll-out in South 
Africa. We will use clinical case studies to highlight common diagnostic 
decision points as a mechanism to educate clinicians on laboratory tools 
and interpretation of results. Immunopaedia is an immediate source 
of information for professionals and represents an effective means for 
learning and dissemination of immunology information. Our aim is to 
integrate immunology into clinical options for patient management.
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